FDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drug
May 19, 2020 at 13:41 PM EDT
The FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of "serious heart rhythm problems."
